Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations-Reference-Cited by-同舟云学术

Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations

Author:

Bayraktar Soley¹²^ORCID,Zhou Jade Z.²,Bassett Roland³,Gutierrez Barrera Angelica M.⁴,Layman Rachel M.⁴,Valero Vicente⁴,Arun Banu⁴^ORCID

Affiliation:

1. Division of Medical Oncology and Hematology Department of Medicine Biruni University School of Medicine Istanbul Turkey

2. Departments of Cancer Medicine The University of Texas M.D. Anderson Cancer Center Houston TexasUSA

3. Biostatistics The University of Texas M.D. Anderson Cancer Center Houston TexasUSA

4. Breast Medical Oncology The University of Texas M.D. Anderson Cancer Center Houston TexasUSA

Funder

Cancer Center Support Grant

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

Reference39 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Hereditary Breast Cancer Non-CDH1 Associated;Hereditary Gastric and Breast Cancer Syndrome;2023